637 related articles for article (PubMed ID: 14552700)
21. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
22. [COX-2 inhibitor to whom?].
Martio J
Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
[No Abstract] [Full Text] [Related]
23. Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept.
Gaddi A; Cicero AF; Pedro EJ
Arch Gerontol Geriatr; 2004; 38(3):201-12. PubMed ID: 15066307
[TBL] [Abstract][Full Text] [Related]
24. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
25. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.
Dermond O; Rüegg C
Drug Resist Updat; 2001 Oct; 4(5):314-21. PubMed ID: 11991685
[TBL] [Abstract][Full Text] [Related]
26. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
Flower RJ
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578
[TBL] [Abstract][Full Text] [Related]
27. [Safe use of anti-inflammatory analgesics].
Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
[No Abstract] [Full Text] [Related]
28. Mechanism of action of antiinflammatory drugs.
Vane JR; Botting RM
Int J Tissue React; 1998; 20(1):3-15. PubMed ID: 9561441
[TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
Howard PA; Delafontaine P
J Am Coll Cardiol; 2004 Feb; 43(4):519-25. PubMed ID: 14975457
[TBL] [Abstract][Full Text] [Related]
30. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
[TBL] [Abstract][Full Text] [Related]
31. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
Stańczyk J; Kowalski ML
Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
[TBL] [Abstract][Full Text] [Related]
32. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
34. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
35. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
Monsuez JJ
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
[TBL] [Abstract][Full Text] [Related]
36. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
Buttar NS; Wang KK
Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
[TBL] [Abstract][Full Text] [Related]
37. Safety of anti-inflammatory treatment--new ways of thinking.
Brune K
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i16-20. PubMed ID: 14752171
[TBL] [Abstract][Full Text] [Related]
38. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
39. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
Wigand R
Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
[No Abstract] [Full Text] [Related]
40. COX-2 inhibition and the control of pain.
Kiefer W; Dannhardt G
Curr Opin Investig Drugs; 2002 Sep; 3(9):1348-58. PubMed ID: 12498012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]